Translation
	October 19, 2005
	Name of listed company:   Chugai Pharmaceutical Co., Ltd. Code number: 4519 (1st Section of Tokyo Stock Exchange) Head office: 1-1, Nihonbashi-Muromachi 2-chome, Chuo-ku, Tokyo President & CEO: Osamu Nagayama Inquiries to: Shizuo Kagoshima, General Manager, Corporate Communications Dept. Tel: +81-(0)3-3273-0881

F. Hoffmann-La Roche Announces Third Quarter Sales 2005

F. Hoffmann-La Roche Ltd. (hereafter "Roche") [Head Office: Basel, Switzerland. Chairman and CEO: Franz B. Humer] announced today, its third quarter sales 2005 (January 1 - September 30, 2005) Roche owns 50.1% of Chugai's outstanding shares (50.6% of voting rights) since October 1, 2002 (as of June 30, 2005). Its presentation materials can be found on its Website (http://www.roche.com).

Chugai's sales for the period of January 1 to September 30, 2005 are included in the announced Roche Group's sales. These results are based on Roche's accounting policies which conform to International Financial Reporting Standards, which differ from generally accepted accounting standards in Japan.

Chugai's third quarter results for fiscal 2005 (January - September, 2005) are scheduled to be announced on October 20, 2005.